Articles on key issues related to the pharma industry from the heads of leading pharmaceutical companies and pharma industry experts across the globe. The pharma industry articles' section focuses on current and emerging issues in areas such as Strategic developments in the pharma industry, pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical manufacturing, biopharmaceuticals, and information technology.
The incorporation of Artificial Intelligence AI in the discovery and development of drugs represents a significant step towards transforming drug delivery systems
The traditional pharmaceutical approach of designing a diseasesymptomspecific drug has historically proven effective However this methodology often falls short due to the complex and often multifactorial etiology of diseases
As Asia establishes itself as the global hub for clinical trials Singapore is bolstering its position as the preferred location for these trials to take place The countrys strong RD capabilities talent pool world class healthcare infrastructure and robust regulatory
As the global pharma industry continues its shift towards precision medicine in the quest for targeting undruggable targets research and development activities have experienced a tremendous surge
In an era marked by remarkable medical advancements a disquieting paradox is staring at us While many parts of the world face a growing threat of antimicrobial resistance owing to overuse of antibiotics several low and middle income countries
India as a potential hub for pharmaceutical investors to meet the global crisis of drugs
The Indian Pharmaceuticals industry has emerged globally as one of the fastest growing industries The pharmaceutical industry in India is expected to reach Bn by and Bn by The pharmaceutical industry
Regulatory affairs in the pharmaceutical industry encompass a broad and complex field that is essential for the development approval and postmarketing surveillance of pharmaceutical products This domain acts as the critical nexus between pharmaceutical companies
Asias healthcare landscape is undergoing a transformative journey grappling with profound challenges in changing demographics persistent health inequities and the rising burden of increased disease prevalence
As societies in Asia grow older chronic diseases are becoming more and more prevalent They place serious strain not only on patients but also on caregivers and the healthcare system
Since seminal work by Dr Mitra from Tata Medical Centre has been done on Cellfree chromatin particles that are released upon cell death When cancer cells die the skeletons of mutated cell free
